Italian drugmaker Philogen has announced its decision to voluntarily withdraw the application for marketing authorization to ...

Canalevia-CA1, a canine-specific formulation of crofelemer, Jaguar's novel, oral plant-based drug sustainably harvested from the Croton lechleri tree, is available from multiple leading veterinary ...

Enrollment in company’s first-of-its-kind placebo-controlled Phase 2 study to evaluate the efficacy of crofelemer for ...

The European Medicines Agency will now assess whether this designation should be maintained. ... Cite this: Italian Duchenne Muscular Dystrophy Drug Gets OK in Europe - Medscape - April 30, 2025.

The Italian Medicines Agency is ready to evaluate the reimbursement of new drugs against obesity, following the British model. This was announced by the president of Aifa, Robert Nisticò: 'As soon ...

Italian charity seeks EMA approval for rescued gene therapy. ... The therapy has been available in Italy since August 2023 under a determination by the Italian Medicines Agency (AIFA), which allows ...

Review of African Political Economy, Vol. 46, No. 161, Special Issue: Economic fraud in neoliberal Africa: power, accumulation and class formation (September 2019), pp. 442-458 (17 pages) In recent ...

The year before, 56 of these drugs were being reimbursed by the Italian health authority, with a €1.15 billion price tag, according to researchers from the Italian Medicines Agency (AIFA).

The Italian Medicines Agency AIFA and the Italian Ministry of Health have granted formal approval for NEUROBIS; a multi-centre Phase II study to evaluate safety, and efficacy of an Avextra oral ...

NEUROBIS is one of the few randomised, placebo controlled, double-blind trial with a Cannabis-based medicine to be conducted at multiple sites in Italy and a study of this robust scientific nature ...

The Italian Medicines Agency AIFA and the Italian Ministry of Health have granted formal approval for NEUROBIS; a multi-centre Phase II study to evaluate safety, and efficacy of an Avextra oral ...